ELIZABETH WALSH: Open Payments
NPI 1407308307 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 89 payments from 20 companies in 2025. Trend: 2023 $1,926 · 2024 $1,994 · 2025 $1,953
Food & beverage: $1,953
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 23 | $502 |
| Viatris Specialty LLC | 13 | $303 |
| United Therapeutics Corporation | 12 | $277 |
| Insmed, Inc. | 6 | $180 |
| AstraZeneca Pharmaceuticals LP | 9 | $161 |
| GlaxoSmithKline, LLC. | 5 | $98 |
| GENZYME CORPORATION | 2 | $71 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $63 |
| Amgen Inc. | 3 | $43 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
Products named: Ohtuvayre, YUPELRI, Tyvaso, Arikayce, TEZSPIRE, DUPIXENT, AIRSUPRA, LUMRYZ.
Industry payments across NC — which companies pay providers there.
